|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.948
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.942
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.923
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.912
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.905
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.893
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.826
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.800
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.796
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.793
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.790
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.783
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.768
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.741
|
|
|
|
regulation of ryanodine sensitive calcium release channel activity
|
GO:0060314 |
10 |
0.741
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.732
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.731
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.718
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.710
|
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.703
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.695
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.682
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.669
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.668
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.657
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.643
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.631
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.624
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.614
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.609
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.606
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.603
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.585
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.558
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.552
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.551
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.520
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.463
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.437
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.436
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.430
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.428
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.407
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.407
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.396
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.387
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.385
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.385
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.380
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.376
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.364
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.362
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.361
|
|
|
|
forward locomotion
|
GO:0043056 |
1 |
0.344
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.337
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.332
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.323
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.322
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.311
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.307
|
|
|
|
regulation of sodium ion transmembrane transport
|
GO:1902305 |
9 |
0.298
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.296
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.295
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.295
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.280
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.269
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.261
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.260
|
|
|
|
regulation of sodium ion transmembrane transporter activity
|
GO:2000649 |
9 |
0.257
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.255
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.252
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.251
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.246
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.246
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.242
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.237
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.236
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.223
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.222
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.219
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.216
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.216
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.213
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.212
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.202
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.202
|
|
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
11 |
0.201
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.194
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.192
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.173
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.172
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.169
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.168
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.168
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.167
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.166
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.166
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.165
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.163
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.160
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.159
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.156
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.154
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.152
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.149
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.139
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.139
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.138
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.138
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.133
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.131
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.131
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.129
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.128
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.126
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.125
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.117
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.115
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.115
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.113
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.109
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.108
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.108
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.106
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.106
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.105
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.104
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.103
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.101
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.098
|
|
|
|
synaptic transmission involved in micturition
|
GO:0060084 |
3 |
0.097
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.095
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.095
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.095
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.094
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.094
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.091
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.091
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.091
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.090
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.089
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.088
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.085
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.085
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
0 |
0.081
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.080
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
12 |
0.079
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.079
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.076
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.075
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.074
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.074
|
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.072
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.072
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.071
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.070
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.070
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.070
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.067
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.066
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.066
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.065
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.064
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
15 |
0.063
|
|
|
|
regulation of circadian sleep wake cycle rem sleep
|
GO:0042320 |
1 |
0.063
|
|
|
|
regulation of relaxation of muscle
|
GO:1901077 |
8 |
0.063
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.062
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.062
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.061
|
|
|
|
positive regulation of sodium ion transmembrane transporter activity
|
GO:2000651 |
3 |
0.060
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.060
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.059
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.059
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.058
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.058
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.058
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.058
|
|
|
|
baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001982 |
2 |
0.058
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.057
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.056
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.056
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.055
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.055
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.055
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.055
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.055
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.055
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.053
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.053
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.052
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.051
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.050
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.050
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.050
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.049
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
11 |
0.049
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.049
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.049
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.049
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.049
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.049
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.048
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.048
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.048
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.048
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.047
|
|
|
|
peptidyl cysteine modification
|
GO:0018198 |
8 |
0.047
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.046
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.046
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.045
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.045
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.045
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.045
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.045
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.045
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.044
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.044
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.044
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.044
|
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.043
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.043
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.043
|
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.043
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.043
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.043
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.043
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.042
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.042
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.042
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.042
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.041
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.041
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.041
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.040
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.040
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.039
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.039
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.039
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.038
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.038
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.038
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.038
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.038
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.037
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.037
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.037
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.036
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.036
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.035
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.035
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.035
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.034
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.034
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.034
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.033
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.033
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.033
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.033
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.033
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.033
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.033
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.033
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.032
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.032
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.032
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
9 |
0.032
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.032
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.031
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.031
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.031
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.031
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.031
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.031
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.031
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.031
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.030
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.030
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.029
|
|
|
|
regulation of skeletal muscle contraction by calcium ion signaling
|
GO:0014722 |
3 |
0.029
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.029
|
|
|
|
mitochondrion degradation
|
GO:0000422 |
3 |
0.029
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.029
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.029
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.029
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.029
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.029
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.029
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.028
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.028
|
|
|
|
membrane repolarization
|
GO:0086009 |
7 |
0.028
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.028
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.028
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.028
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.028
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.027
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.027
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.027
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.027
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.027
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.027
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.027
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.026
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.026
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.026
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.026
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.026
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.026
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.026
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.025
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.025
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.025
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.025
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.025
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.025
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.025
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.025
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.025
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.025
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.025
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.025
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.025
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.025
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.025
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.024
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.024
|
|
|
|
negative regulation of tyrosine phosphorylation of stat5 protein
|
GO:0042524 |
2 |
0.024
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.024
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.024
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.024
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.024
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.024
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.024
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.024
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.024
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.024
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.023
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.023
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.023
|
|
|
|
plasma membrane repair
|
GO:0001778 |
7 |
0.023
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.023
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.023
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.023
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.023
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.023
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.023
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.023
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.023
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.023
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.023
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
2 |
0.023
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.023
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.022
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.022
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.022
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.022
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.022
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.022
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.022
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.022
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.022
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.021
|
|
|
|
regulation of synaptic activity
|
GO:0060025 |
1 |
0.021
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.021
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.021
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.021
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.021
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.021
|
|
|
|
translation
|
GO:0006412 |
93 |
0.021
|
|
|
|
positive regulation of transporter activity
|
GO:0032411 |
17 |
0.021
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.021
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.021
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.021
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.021
|
|
|
|
lateral geniculate nucleus development
|
GO:0021771 |
1 |
0.021
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.020
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.020
|
|
|
|
protein palmitoylation
|
GO:0018345 |
14 |
0.020
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.020
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.020
|
|
|
|
regulation of metalloenzyme activity
|
GO:0048552 |
4 |
0.020
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.020
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.020
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.020
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.020
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.020
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
16 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.020
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.019
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.019
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.019
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.019
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.019
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.019
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.019
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.019
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.019
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.019
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.019
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.019
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.019
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.018
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.018
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.018
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.018
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.018
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.018
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.018
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.018
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.018
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.018
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.018
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.018
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.018
|
|
|
|
mating behavior sex discrimination
|
GO:0048047 |
1 |
0.018
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.018
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.018
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.018
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.018
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.018
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
23 |
0.018
|
|
|
|
tyrosine phosphorylation of stat5 protein
|
GO:0042506 |
9 |
0.018
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.018
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.018
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.018
|
|
|
|
negative regulation of transporter activity
|
GO:0032410 |
7 |
0.018
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.018
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.018
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.017
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.017
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.017
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.017
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.017
|
|
|
|
response to copper ion
|
GO:0046688 |
3 |
0.017
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.017
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.017
|
|
|
|
multicellular organismal movement
|
GO:0050879 |
16 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.017
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.017
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
11 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.017
|
|
|
|
relaxation of cardiac muscle
|
GO:0055119 |
9 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.017
|
|